202 related articles for article (PubMed ID: 19700404)
1. Structural model for phenylalkylamine binding to L-type calcium channels.
Cheng RCK; Tikhonov DB; Zhorov BS
J Biol Chem; 2009 Oct; 284(41):28332-28342. PubMed ID: 19700404
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels.
Huber IG; Wappl-Kornherr E; Sinnegger-Brauns MJ; Hoda JC; Walter-Bastl D; Striessnig J
J Biol Chem; 2004 Dec; 279(53):55211-7. PubMed ID: 15504730
[TBL] [Abstract][Full Text] [Related]
3. Structural model for dihydropyridine binding to L-type calcium channels.
Tikhonov DB; Zhorov BS
J Biol Chem; 2009 Jul; 284(28):19006-17. PubMed ID: 19416978
[TBL] [Abstract][Full Text] [Related]
4. Phenylalkylamines in calcium channels: computational analysis of experimental structures.
Tikhonov DB; Lin L; Yang DSC; Yuchi Z; Zhorov BS
J Comput Aided Mol Des; 2020 Nov; 34(11):1157-1169. PubMed ID: 32648151
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel.
Lipkind GM; Fozzard HA
Mol Pharmacol; 2003 Mar; 63(3):499-511. PubMed ID: 12606756
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site.
Degtiar VE; Aczél S; Döring F; Timin EN; Berjukow S; Kimball D; Mitterdorfer J; Hering S
Biophys J; 1997 Jul; 73(1):157-67. PubMed ID: 9199780
[TBL] [Abstract][Full Text] [Related]
7. Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A.
Döring F; Degtiar VE; Grabner M; Striessnig J; Hering S; Glossman H
J Biol Chem; 1996 May; 271(20):11745-9. PubMed ID: 8662622
[TBL] [Abstract][Full Text] [Related]
8. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
[TBL] [Abstract][Full Text] [Related]
9. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.
Zhorov BS; Folkman EV; Ananthanarayanan VS
Arch Biochem Biophys; 2001 Sep; 393(1):22-41. PubMed ID: 11516158
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations.
Cosconati S; Marinelli L; Lavecchia A; Novellino E
J Med Chem; 2007 Apr; 50(7):1504-13. PubMed ID: 17335186
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit.
Hockerman GH; Johnson BD; Abbott MR; Scheuer T; Catterall WA
J Biol Chem; 1997 Jul; 272(30):18759-65. PubMed ID: 9228049
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for inhibition of a voltage-gated Ca
Tang L; Gamal El-Din TM; Swanson TM; Pryde DC; Scheuer T; Zheng N; Catterall WA
Nature; 2016 Sep; 537(7618):117-121. PubMed ID: 27556947
[TBL] [Abstract][Full Text] [Related]
13. Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes.
Wegener JW; Nawrath H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):322-30. PubMed ID: 8584049
[TBL] [Abstract][Full Text] [Related]
14. Why does the inner-helix mutation A413C double the stoichiometry of Kv1.3 channel block by emopamil but not by verapamil?
Rossokhin A; Dreker T; Grissmer S; Zhorov BS
Mol Pharmacol; 2011 Apr; 79(4):681-91. PubMed ID: 21220411
[TBL] [Abstract][Full Text] [Related]
15. Inactivation determinant in the I-II loop of the Ca2+ channel alpha1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (-)gallopamil.
Sokolov S; Weiss RG; Kurka B; Gapp F; Hering S
J Physiol; 1999 Sep; 519 Pt 2(Pt 2):315-22. PubMed ID: 10457051
[TBL] [Abstract][Full Text] [Related]
16. Probing the architecture of an L-type calcium channel with a charged phenylalkylamine: evidence for a widely open pore and drug trapping.
Beyl S; Timin EN; Hohaus A; Stary A; Kudrnac M; Guy RH; Hering S
J Biol Chem; 2007 Feb; 282(6):3864-70. PubMed ID: 17138559
[TBL] [Abstract][Full Text] [Related]
17. Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca
Zhao Y; Huang G; Wu J; Wu Q; Gao S; Yan Z; Lei J; Yan N
Cell; 2019 May; 177(6):1495-1506.e12. PubMed ID: 31150622
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines.
Johnson BD; Hockerman GH; Scheuer T; Catterall WA
Mol Pharmacol; 1996 Nov; 50(5):1388-400. PubMed ID: 8913371
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of benzothiazepine binding in the L-type calcium channel.
Tikhonov DB; Zhorov BS
J Biol Chem; 2008 Jun; 283(25):17594-604. PubMed ID: 18397890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
